Top Markets
#1 ADO Protocol ADO Protocol +192.98%
#2 Islamic Coin Islamic Coin +155.39%
#3 GoPlus Security GoPlus Security +53.98%
#4 GAIB AID GAIB AID +24.67%
#5 Starpower Starpower +19.26%
#6 o1.exchange o1.exchange +14.05%
#7 Verus Coin Verus Coin +13.56%
#8 Chia Chia +12.95%
#9 Tutorial Tutorial +12.05%
#10 Casper Network Casper Network +10.77%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Classement en actions #33504
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Prix de l'action
$1.12
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.52M
Changement (1 jour)
4.51%
Changement (1 an)
-94.79%
Pays
US
Échange NeoImmuneTech, Inc. (950220)

Catégorie

Healthcare
Ratio P/B pour NeoImmuneTech, Inc. (950220)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de NeoImmuneTech, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour NeoImmuneTech, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE